In order to estimate the relative magnitude of the two alternative pathways of monodeiodination of thyroxine (T4) in adult humans, the metabolic clearance rates (MCR) and production rates (PR) of 3,3′,5′-triiodothyronine (reverse-T3) rT3) and of 3,5,3′-triiodothyronine (T3) were determined in six euthyroid control subjects (C) and in five hypothyroid patients (H) receiving L-T4 as replacement therapy (0.15–0.3 mg/day). MCR was computed by a non-compartmental method of analysis from the plasma disappearance of 125I rT3 and 131I T3 during 72 h following simultaneous injection of tracers. PR was calculated from MCR and the serum concentration of rT3 and T3, respectively, determined by radioimmunoassay. In the H subjects, rT3 MCR averaged 97.1± 12.8 (SD) I/day and rT3 PR, 34.3± 12.8 /βg/day; T3 MCR was 28.7± 6.1 I/day and T3 PR, 20.3± 6.6 /βg/day (all corrected to 70 kg body weight). These results were not significantly different from those in the control group: rT3 MCR 104± 24 I/day, rT3 PR 33.0± 9.2 /βg/day; T3 MCR 24.0± 5.9, T3 PR 24.2± 4.1. The proportion of total triiodothyronine (rT3 +T3) production accounted for by rT3 averaged 62% in H patients and was similar (57%) in the C group. The results obtained in the H subjects indicate that the production of rT3 is a major route of T4 metabolism, equal to or exceeding that of T3. From the close agreement between the mean values for rT3 PR in the C and H groups it is concluded that most, if not all of the rT3 produced in normal humans is derived by extrathyroidal conversion from T4